Keyword Analysis & Research: mtnb
Keyword Research: People who searched mtnb also searched
Search Results related to mtnb on Search Engine
-
Matinas BioPharma Holdings, Inc. (MTNB) - Yahoo Finance
https://finance.yahoo.com/quote/MTNB
webFind the latest Matinas BioPharma Holdings, Inc. (MTNB) stock quote, history, news and other vital information to help you with your stock trading and investing.
DA: 61 PA: 8 MOZ Rank: 48
-
Matinas BioPharma Holdings, Inc. (MTNB) - Yahoo Finance
https://finance.yahoo.com/quote/MTNB/profile
webSee the company profile for Matinas BioPharma Holdings, Inc. (MTNB) including business summary, industry/sector information, number of employees, business summary, corporate governance, key ...
DA: 16 PA: 12 MOZ Rank: 34
-
Matinas BioPharma Holdings, Inc. (MTNB) - Stock Analysis
https://stockanalysis.com/stocks/mtnb/company/
web3 days ago · 1545 Route 206 South, Suite 302 Bedminster, New Jersey 07921 United States
DA: 44 PA: 77 MOZ Rank: 82
-
Matinas BioPharma Holdings, Inc. (MTNB) - Stock Analysis
https://stockanalysis.com/stocks/mtnb/
webMar 20, 2024 · Financial Performance. In 2022, MTNB's revenue was $3.19 million, an increase of 9560.61% compared to the previous year's $33,000. Losses were -$21.00 million, -11.33% less than in 2021. Financial Statements.
DA: 56 PA: 97 MOZ Rank: 72
-
MTNB Matinas BioPharma Holdings, Inc. - Seeking Alpha
https://seekingalpha.com/symbol/MTNB
webOct 1, 2014 · A high-level overview of Matinas BioPharma Holdings, Inc. (MTNB) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
DA: 44 PA: 22 MOZ Rank: 3
-
Matinas Biopharma Holdings Inc MTNB Overview - U.S. News
https://money.usnews.com/investing/stocks/mtnb-matinas-biopharma-holdings-inc
web6 days ago · Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery ...
DA: 91 PA: 33 MOZ Rank: 40
-
Matinas BioPharma stock spikes on data for oral chemotherapy
https://seekingalpha.com/news/4031705-matinas-biopharma-stock-spikes-data-oral-chemotherapy
webNov 7, 2023 · Matinas BioPharma spikes on pre-clinical data for oral chemotherapy. Matinas BioPharma ( NYSE: MTNB) added ~14% pre-market Tuesday after announcing positive findings from a pre-clinical study ...
DA: 8 PA: 54 MOZ Rank: 54
-
Matinas BioPharma (NYSEAMERICAN:MTNB) Issues Earnings …
https://www.marketbeat.com/instant-alerts/nyseamerican-mtnb-earnings-announcement-2024-03-28/
web17 hours ago · March 28, 2024. → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press)(Ad) Matinas BioPharma ( NYSEAMERICAN:MTNB - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.03) earnings per share for the quarter, Yahoo Finance reports. Get Matinas BioPharma alerts:
DA: 58 PA: 30 MOZ Rank: 85
-
Matinas Biopharma GAAP EPS of -$0.11, revenue of $1.1M
https://seekingalpha.com/news/4084678-matinas-biopharma-gaap-eps-of-0_11-revenue-of-1_1m
web20 hours ago · Matinas Biopharma press release ( NYSE: MTNB ): FY GAAP EPS of -$0.11. Revenue of $1.1M (-65.5% Y/Y). Cash, cash equivalents and marketable securities as of December 31, 2023 were $13.8 million ...
DA: 54 PA: 81 MOZ Rank: 84
-
Matinas BioPharma Announces Positive in vivo Safety Data
https://www.globenewswire.com/news-release/2024/03/25/2851549/32419/en/Matinas-BioPharma-Announces-Positive-in-vivo-Safety-Data-with-its-Oral-LNC-Docetaxel-Formulation.html
web3 days ago · BEDMINSTER, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking ...
DA: 81 PA: 39 MOZ Rank: 22